RODM - ETF AI Analysis

Top Page

Hartford Multifactor Developed Markets (ex-US) ETF (RODM)

Rating:64Neutral

Price Target:―

RODM, the Hartford Multifactor Developed Markets (ex-US) ETF, earns a solid overall rating thanks to several high-quality international blue chips like Novartis, GSK, and major banks such as Toronto-Dominion and Royal Bank of Canada, which bring strong financial performance, resilient earnings, and reasonable valuations. These strengths are partly offset by holdings like Nokia and Centrica, where profitability, cash flow, or valuation concerns introduce some drag, and by signs of overbought conditions in several names, which adds short-term market risk.

Positive Factors

Broad Country Diversification

The fund spreads its investments across many developed markets outside the U.S., which helps reduce the impact of problems in any single country.

Balanced Sector Mix

Holdings are spread across financials, industrials, health care, consumer sectors, and more, limiting reliance on any one part of the economy.

Solid Recent Performance Trend

The ETF has shown steady gains over the last few months, indicating improving momentum in its underlying markets.

Negative Factors

Heavy Tilt Toward Financials

A large share of the portfolio is in financial companies, which can make the fund more sensitive to banking and interest-rate risks.

Mixed Results Among Top Holdings

Some of the largest positions, including several banks and other companies, have shown weaker performance this year, which can drag on overall returns.

Moderate Expense Ratio

The fund’s fee is not especially low for a broad developed-markets ETF, which slightly reduces the net return investors keep over time.

RODM vs. SPDR S&P 500 ETF (SPY)

AUM1.43B

RegionDeveloped Markets

Expense Ratio0.29%

Beta0.47

IssuerHartford

Inception DateFeb 25, 2015

Dividend Yield2.84%

Asset ClassEquity

Index TrackedHartford Risk-Optimized Multi Developed Markets Ex-US Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume74,740

30 Day Avg. Volume95,244

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

42.07

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering318

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

RODM Summary

RODM is the Hartford Multifactor Developed Markets (ex-US) ETF, which tracks the Hartford Risk-Optimized Multi Developed Markets Ex-US Index. It invests in a wide range of companies from developed countries outside the U.S., including Japan, the UK, Canada, and more. The fund holds well-known names like Nokia, Roche, and Royal Bank of Canada, and spreads money across many sectors such as financials, industrials, and health care. Someone might invest in RODM to diversify beyond the U.S. stock market and seek long-term growth. Risk: the value can go up and down with international markets and currency swings.

How much will it cost me?The Hartford Multifactor Developed Markets (ex-US) ETF (RODM) has an expense ratio of 0.29%, which means you’ll pay $2.90 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs, as it uses a multifactor strategy to optimize returns and manage risk.

What would affect this ETF?RODM’s focus on developed markets outside the U.S. could benefit from economic recovery or growth in regions like Europe and Asia, particularly in sectors such as financials and healthcare, which have significant weight in the ETF. However, challenges like rising interest rates, geopolitical tensions, or regulatory changes in these regions could negatively impact the performance of its top holdings, including companies like Nokia and Roche Holding AG. Additionally, currency fluctuations between the U.S. dollar and foreign currencies may influence returns for U.S.-based investors.

RODM Top 10 Holdings

RODM’s story is all about steady leadership from big non-U.S. banks and health care giants, with a supporting cast in utilities and energy. Canadian banks like Toronto-Dominion, Royal Bank of Canada, and Bank of Montreal have been generally rising over the past few months, helping to pull the fund forward, even if TD and RBC have recently lost a bit of steam. On the health care side, Roche and Novartis are solid climbers, while GSK looks more mixed. Engie and Centrica add a lift from Europe’s utility and energy space. Overall, it’s a diversified developed-markets ex-U.S. play, with notable strength in financials and European blue chips.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NOK	Nokia	1.49%	$21.27M	$41.08B	57.29%	66 Neutral
GSK	GlaxoSmithKline	1.30%	$18.47M	$123.00B	62.44%	77 Outperform
ENGI	Engie SA	1.24%	$17.61M	€64.94B	64.26%	64 Neutral
ROG	Roche Holding AG	1.23%	$17.55M	CHF294.84B	46.01%	73 Outperform
ORA	ORANGE SA	1.12%	$15.91M	€44.88B	62.70%	65 Neutral
NOVN	Novartis AG	1.09%	$15.52M	CHF242.43B	28.84%	80 Outperform
TD	Toronto Dominion Bank	1.07%	$15.29M	$162.39B	62.11%	74 Outperform
2388	BOC Hong Kong (Holdings)	1.03%	$14.60M	HK$458.86B	66.97%	78 Outperform
	―	1.00%	$14.27M	―	―	―
BMO	Bank Of Montreal	0.99%	$14.15M	C$138.34B	45.33%	74 Outperform

RODM Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

38.09

Positive

100DMA

36.70

Positive

200DMA

35.18

Positive

Market Momentum

MACD

0.78

Negative

RSI

76.04

Negative

STOCH

88.42

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RODM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 39.53, equal to the 50-day MA of 38.09, and equal to the 200-day MA of 35.18, indicating a bullish trend. The MACD of 0.78 indicates Negative momentum. The RSI at 76.04 is Negative, neither overbought nor oversold. The STOCH value of 88.42 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RODM.

RODM Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
RODM	―	―	$1.43B	0.29%	―
GSIE	―	―	$5.44B	0.25%	―
LVHI	―	―	$4.48B	0.40%	―
IMTM	―	―	$3.78B	0.30%	―
INTF	―	―	$3.28B	0.16%	―
IDMO	―	―	$3.17B	0.25%	―

Performance Comparison

RODM

Hartford Multifactor Developed Markets (ex-US) ETF

40.64

11.40

38.99%

GSIE

Goldman Sachs ActiveBeta International Equity ETF

―

LVHI

Legg Mason International Low Volatility High Dividend ETF

―

IMTM

iShares MSCI Intl Momentum Factor ETF

―

INTF

iShares MSCI Intl Multifactor ETF

―

IDMO

Invesco S&P International Developed Momentum ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents